Optimization of Asthma Treatment Through Exhaled NO for Increased Asthma-Related Quality of Life (NOAK)

The purpose of this study is to determine whether use of exhaled NO (nitric oxide) to regulate the anti-inflammatory treatment leads to increased asthma-related quality of life in patients with allergic asthma

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Allergic Asthma Asthma Bronchial Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Inflammation Lung Diseases Lung Diseases, Obstructive Pathologic Processes Pathological Conditions, Signs and Symptoms Respiratory Hypersensitivity Respiratory Tract Diseases

Age range

18 year–64 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Runby Primary Health Care Center

Upplands Vasby, Sweden

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age 18-64
Clinical diagnosis of Asthma
Glucocorticoid treatment > 6 months.
Verified Allergy
Read and speak Swedish

Exclusion criteria

Smoking
Current regular treatment with long-acting beta2-agonist
Treatment with Singulair only or in combination with glucocorticoids
Taking part in other research study
Pregnancy or breast-feeding
Unstable Asthma

Treatment and study plan

Single corticosteroid inhalers and Singulair

Drug

Treatment steps according to preset algorithm

Primary outcomes

Mini-AQLQ (Asthma-Related Quality of Life)

Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Karolinska Institutet

Other

Collaborators

Aerocrine AB
Meda AB
Merck Sharp & Dohme LLC
Phadia AB
Region Stockholm
Swedish Council for Working Life and Social Research
The Swedish Research Council
Uppsala University

Registry information

Official study title

Optimization of the Anti-Inflammatory Treatment of Asthma Patients Through Exhaled NO Measurements for Increased Asthma-Related Quality of Life in Primary Health Care (NOAK)

Important dates

Study start: 2006
Primary completion: 2010
Study completion: 2010
First posted: Jan 11, 2007
Registry last updated: Aug 15, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed